Participants, n (%) | Non-participants, n (%) | |
---|---|---|
All | 131 (52.4) | 119 (47.6) |
Demographic characteristics | ||
Gender* | ||
Female | 98 (75) | 86 (72) |
Male | 33 (25) | 33 (28) |
Age* | 65 (9.5), 41-86 | 66 (11.4), 39-90 |
Mean (SD), min-max | ||
<60 years | 38 (29) | 40 (34) |
≥60 years | 93 (71) | 78 (66) |
Years since diagnosis* | 3.09 (1.65-6.01) | 3.89 (2.03-6.76) |
Median (IQR) | ||
<3 years | 60 (46) | 46 (39) |
≥3 years | 70 (54) | 71 (61) |
Marital status # | ||
Not living with a partner | 28 (22) | - |
Living with a partner | 102 (78) | - |
Children # | ||
No children living at home | 114 (89) | - |
Children living at home | 14 (11) | - |
Education # | ||
No higher education | 70 (57) | - |
Higher education | 56 (44) | - |
Occupation # | ||
Not retired | 47 (37) | - |
Retired | 80 (63) | - |
Clinical characteristics | ||
Comorbidity | ||
No comorbidity | 40 (32) | - |
Comorbidity | 95 (68) | - |
Cancer type* | ||
Breast | 90 (71) | 82 (69) |
Prostate | 27 (21) | 22 (19) |
Colorectal | 10 (8) | 11 (9) |
Other | 0 (0) | 3 (3) |
Treatment* | ||
Surgery | 96 (74) | 92 (78) |
Radiation therapy | 79 (61) | 66 (56) |
Chemotherapy | 68 (52) | 64 (54) |
Hormone therapy | 100 (77) | 85 (72) |
Other pharmaceutical | 17 (13) | 13 (11) |
Other treatments | 3 (2) | 2 (2) |
No treatment | 4 (3) | 2 (2) |